01 1NEWCHEM SPA
02 2STERLING SPA
01 3NOMEGESTROL ACETATE
01 3Italy
NDC Package Code : 24002-0013
Start Marketing Date : 2009-08-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-1002
Start Marketing Date : 2011-11-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-1004
Start Marketing Date : 2020-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Nomegestrol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nomegestrol Acetate, including repackagers and relabelers. The FDA regulates Nomegestrol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nomegestrol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nomegestrol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nomegestrol Acetate supplier is an individual or a company that provides Nomegestrol Acetate active pharmaceutical ingredient (API) or Nomegestrol Acetate finished formulations upon request. The Nomegestrol Acetate suppliers may include Nomegestrol Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Nomegestrol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nomegestrol Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nomegestrol Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nomegestrol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nomegestrol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nomegestrol Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nomegestrol Acetate suppliers with NDC on PharmaCompass.
We have 2 companies offering Nomegestrol Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
